WallStreetZenWallStreetZen

NASDAQ: OPTN
Optinose Inc Earnings & Revenue

OPTN past revenue growth

How has OPTN's revenue growth performed historically?
Company
-7.64%
Industry
9.75%
Market
17.81%
OPTN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OPTN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OPTN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OPTN earnings and revenue history

Current Revenue
$72.0M
Current Earnings
-$40.7M
Current Profit Margin
-56.6%

OPTN Return on Equity

Current Company
N/A
Current Industry
10.7%
Current Market
-8.4%

Be the first to know when OPTN announces earnings.

OPTN Return on Assets

Current Company
-34.9%
Current Industry
2.9%
OPTN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OPTN Return on Capital Employed

Current Company
34.84%
Current Industry
5.5%
OPTN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OPTN vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OPTN$71.98M-$21.39M-$40.72M+77.89%N/A
ALIM$68.48M-$6.60M-$21.39M+11.01%N/A
AQST$48.06M-$4.76M-$12.11M-5.21%N/A
OGIN/AN/AN/AN/AN/A
ACB$199.23M-$66.17M-$106.90M+17.87%N/A

OPTN earnings dates

Next earnings date
Mar 5, 2024

Optinose Earnings & Revenue FAQ

What were OPTN's earnings last quarter?

On Invalid Date, Optinose (NASDAQ: OPTN) reported Q3 2023 earnings per share (EPS) of -$0.08, up 55.56% year over year. Total Optinose earnings for the quarter were -$9.29 million. In the same quarter last year, Optinose's earnings per share (EPS) was -$0.18.

If you're new to stock investing, here's how to buy Optinose stock.

What was OPTN's earnings growth in the past year?

As of Q1 2024, Optinose's earnings has grown year over year. Optinose's earnings in the past year totalled -$40.72 million.

What is OPTN's earnings date?

Optinose's earnings date is Invalid Date. Add OPTN to your watchlist to be reminded of OPTN's next earnings announcement.

What was OPTN's revenue last quarter?

On Invalid Date, Optinose (NASDAQ: OPTN) reported Q3 2023 revenue of $19.82 million up 1.27% year over year. In the same quarter last year, Optinose's revenue was $20.08 million.

What was OPTN's revenue growth in the past year?

As of Q1 2024, Optinose's revenue has grown -7.64% year over year. This is 17.39 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.75%. Optinose's revenue in the past year totalled $71.98 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.